Stock Comparison
MEDP vs TMO
Medpace Holdings Inc and Thermo Fisher Scientific Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$15.93B
$218.35B
P/E (TTM)
33.6
31.8
Forward P/E
33.2
23.5
Price/Sales
5.7
4.7
Price/Book
36.7
4.2
EV/EBITDA
25.4
21.3
Dividend Yield
—
0.30%
Profitability
Net Margin
17.19%
15.18%
Operating Margin
21.02%
17.76%
Return on Equity
162.10%
13.50%
Return on Assets
20.10%
5.13%
Growth (YoY)
Revenue Growth
17.20%
10.50%
Earnings Growth
37.10%
9.40%
Price & Risk
Beta
1.2
0.8
52-Week High
$620.59
$638.80
52-Week Low
$393.42
$438.34
Analyst Target
$581.83
$631.42
Compare MEDP and TMO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.